Investors in Iot

Partnerinvest Norr is a venture capital firm operating in Norr- and Västerbotten, established in 2010 through Norrlandsfonden and Almi Invest. They specialize in investing in companies with scalable business models and driven entrepreneurs across diverse industries. Unlike typical venture capital firms, Partnerinvest Norr focuses on northern Sweden and collaborates with private investment partners to provide substantial capital and extensive networks. Their Investment Managers bring extensive regional industry knowledge and experience in equity capital investments.

Linc invests in product oriented companies in the Nordic Life Science industry – primarily in pharmaceutical and medical technology companies. Their investments in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses.

Starbright Invest focuses on investing in entrepreneur-led, scalable companies with the potential for significant growth, particularly in technology and digital innovation that promotes sustainable development. We are actively committed to supporting our portfolio companies and aim for investments of €0.5-1.5 million.

Confidus Venture Capital, part of the family-owned Beijer Holding, invests in digital transformation and automation. Beijer Holding also includes Beijerinvest and holds a controlling stake in Beijer Alma, an international component manufacturing and industrial trade group. Additionally, Beijer Holding supports various organizations focused on entrepreneurship, research, and education, such as the Anders Walls Foundation and the Beijer Institute. Confidus Venture Capital seeks companies with stable ownership, development progress, and strong entrepreneurial cultures to achieve significant growth.

Crosslight Partners tackles substantial challenges within the food system with innovative solutions. These companies are at the early growth stage, demonstrating commercial traction. Investments typically range from SEK 1 to 10 million, with flexible ownership stakes. While the focus is global, emphasis lies on the Nordics and Europe. The investment horizon spans 3 to 7 years, and governance involvement includes securing a board seat or holding quarterly follow-up meetings.

The Nordic region is at the forefront of the technology and scientific revolution. Northislet's vision is to help create and build Nordic champions within Life Science, allowing them to grow and reach their potential in the hands of local entrepreneurs, employees, and shareholders. Their goal is to create long-term value for all stakeholders, fostering a prosperous environment for new and existing companies, entrepreneurs, and scientists, making the Nordic region a competitive and attractive place for global talent within Life Science. Northislet aims to become a leading Nordic investment company in Life Science over the next 25 years, with the journey just beginning.

We focus on healthcare companies within pharma, biotech, medical technology and health care services and; technology companies within software and hardware. We are primarily interested when the capital and competence we add are required for product or market development. We make investments in companies which are still small and where we can make a difference as owners. We invest in several rounds of financing but limit our initial investment to SEK 10 million. We are looking for a high return which typically is achieved through and exit within 3-5 years. Our investors make a difference for the companies we invest in through the board.

NXT2B is a fully privately owned venture capital company capable of making fast investment decisions without requiring external capital. The NXT2B team has proven experience in commercializing innovative projects and partners with competent and ambitious entrepreneurs, focusing on growth equity investments in healthcare, medical devices, and specialty pharmaceutical companies. They are prepared to invest in early-phase projects of high scientific quality and reasonable business potential, as well as in technology and consumer companies with unique ideas. Since its inception in 2011, NXT2B has invested in over 30 companies, offering active support to portfolio management teams to build market-leading companies.

Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies.

Criteria Venture Tech is a versatile Venture Capital fund dedicated to advancing the forefront of technology. They partner with visionary companies across multiple stages of growth, aiming to drive technological innovation forward. Focused on Europe and North America, with a special emphasis on Spain and Portugal, Criteria Venture Tech invests across various stages and verticals including B2B SaaS and Deeptech. They prioritize sectors such as Software Infrastructure, Enterprise Data and Automation, Frontier Tech, and Cybersecurity, providing ongoing support to achieve meaningful impact. Their commitment lies in fostering long-term economic and social value through transformative technological advancements. As part of Caixa Capital Risc and the CriteriaCaixa group, Spain's largest investment holding managing over €25 billion in assets, Criteria Venture Tech leverages a robust financial foundation to support their investment strategies and portfolio companies.

Chamberí Ventures establishes clear criteria for potential investments, ranging from €10,000 to €250,000 per venture. Their focus is on business models that demonstrate revenue generation capabilities and present viable financial plans. They are open to participating in companies at various stages of growth, including seed capital, Series A, Pre-IPO, IPO, and alternative markets, emphasizing the crucial role of team quality in their decision-making process. Regarding exits, they adopt a flexible approach, prioritizing systematic analysis of profitability and risk. Their divestment strategy favors long-term sustainability, aiming to maximize profitability while minimizing sales driven solely by liquidity needs.

Copernion Group operates as a tech corporation dedicated to fostering, investing in, and advising tech startups, leveraging a Corporate Venture structure to offer opportunities for third-party involvement and achieve significant returns. Central to its strategy is the Copernion Circle, an active platform comprising over 350 influential members globally. These professionals, ranging from presidents to CEOs, contribute to Copernion Group's growth and impact across 19 countries, supporting its diverse portfolio of 26 companies. Notably, Copernion Group has catalyzed Spain's sole deep-tech unicorn, delivering substantial returns and generating over 2,400 jobs for young professionals. With operations spanning across Europe, the Americas, and beyond, Copernion Group applies an innovative investment model across various tech sectors, backed by extensive expertise in cutting-edge technologies like AI, Big Data, and Robotics. Their commitment to sustainable investment underscores their focus on creating high societal impact alongside financial success.